The invention discloses a preparation process of a Baloxavir marboxil and L-
tartaric acid eutectic
crystal form. The X-
ray powder diffraction pattern of the Baloxavir marboxil and L-
tartaric acid eutectic
crystal form under Cu-Ka
radiation has
diffraction angle 2theta values of 8.7 + / -0.2 degrees, 10.8 + / -0.2 degrees, 11.6 + / -0.2 degrees, 13.2 + / -0.2 degrees, 13.8 + / -0.2 degrees, 14.3 + / -0.2 degrees, 15.8 + / -0.2 degrees, 16.2 + / -0.2 degrees, 16.4 + / -0.2 degrees, 17.5 + / -0.2 degrees, 18.6 + / -0.2 degrees, 18.9 + / -0.2 degrees, 19.4 + / -0.2 degrees, 19.8 + / -0.2 degrees, 20.1 + / -0.2 degrees, 20.7 + / and characteristic peaks exist at the positions of 25.7 + / -0.2 degrees, 26.4 + / -0.2 degrees, 26.8 + / -0.2 degrees, 27.6 + / -0.2 degrees, 28.3 + / -0.2 degrees, 28.6 + / -0.2 degrees, 29.1 + / -0.2 degrees, 29.7 + / -0.2 degrees, 31.4 + / -0.2 degrees, 32.0 + / -0.2 degrees, 35.4 + / -0.2 degrees, 35.8 + / -0.2 degrees, 36.1 + / -0.2 degrees, 36.7 + / -0.2 degrees and 37.4 + / -0.2 degrees. The Baloxavir marboxil and L-
tartaric acid eutectic
crystal form provided by the invention has stable physicochemical properties, excellent
solid stability and
mechanical stability, and can be stably stored for a long time, the preparation method is simple and convenient, the
repeatability is good, and the Baloxavir marboxil and L-tartaric acid eutectic crystal form has important application value for the development of the
medicine in the future.